BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26096461)

  • 1. Longitudinal changes of dopamine transporters in heroin users during abstinence.
    Xu S; Liu Y; Li Y; Deng Y; Huang Y; Yuan J; Lv R; Wang Y; Zhang G; Guo Z; Han M; Liu X; Fu D
    Psychopharmacology (Berl); 2015 Sep; 232(18):3391-401. PubMed ID: 26096461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine transporter availability in heroin-dependent subjects and controls: longitudinal changes during abstinence and the effects of Jitai tablets treatment.
    Liu Y; Han M; Liu X; Deng Y; Li Y; Yuan J; Lv R; Wang Y; Zhang G; Gao J
    Psychopharmacology (Berl); 2013 Nov; 230(2):235-44. PubMed ID: 23715641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of striatal dopamine transporter levels in chronic heroin-dependent and methamphetamine-dependent subjects.
    Yuan J; Liu XD; Han M; Lv RB; Wang YK; Zhang GM; Li Y
    Addict Biol; 2017 Jan; 22(1):229-234. PubMed ID: 26040446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between heroin expenditure and dopamine transporter availability--a single-photon emission computed tomography study.
    Lin SH; Chen KC; Lee SY; Chiu NT; Lee IH; Chen PS; Yeh TL; Lu RB; Chen CC; Liao MH; Yang YK
    Psychiatry Res; 2015 Mar; 231(3):292-7. PubMed ID: 25659472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients.
    Zaaijer ER; van Dijk L; de Bruin K; Goudriaan AE; Lammers LA; Koeter MW; van den Brink W; Booij J
    Psychopharmacology (Berl); 2015 Jul; 232(14):2597-607. PubMed ID: 25757673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Jitai tablet, a traditional Chinese medicine, on plasma adrenocorticotropic hormone and cortisol levels in heroin addicts during abstinence.
    Fan HY; Sun L; Li XX; Zhou SB; Liang JC; Yan BY; Li Y; Deng YP
    J Altern Complement Med; 2014 Jul; 20(7):527-34. PubMed ID: 24786196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users.
    Shi J; Zhao LY; Copersino ML; Fang YX; Chen Y; Tian J; Deng Y; Shuai Y; Jin J; Lu L
    Eur J Pharmacol; 2008 Jan; 579(1-3):160-6. PubMed ID: 17977528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced striatal dopamine transporter density associated with working memory deficits in opioid-dependent male subjects: a SPECT study.
    Liang CS; Ho PS; Yen CH; Yeh YW; Kuo SC; Huang CC; Chen CY; Shih MC; Ma KH; Huang SY
    Addict Biol; 2016 Jan; 21(1):196-204. PubMed ID: 25439653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between availability of serotonin transporters and time to relapse in heroin users: a two-isotope SPECT small sample pilot study.
    Lin SH; Chen KC; Lee SY; Yao WJ; Chiu NT; Lee IH; Chen PS; Yeh TL; Liao MH; Lu RB; Yang YK
    Eur Neuropsychopharmacol; 2012 Sep; 22(9):647-50. PubMed ID: 22335891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Availability of dopamine transporters in heroin-dependent subjects: A
    Xu S; Liu Y; Li Y; Deng Y; Yuan J; Lv R; Wang Y; Zhang G; Guo Z; Fu D; Zeng H; Han M; Liu X
    Psychiatry Res Neuroimaging; 2017 May; 263():121-126. PubMed ID: 28376406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter dysfunction in Han Chinese people with chronic methamphetamine dependence after a short-term abstinence.
    Yuan J; Lv R; Robert Brašić J; Han M; Liu X; Wang Y; Zhang G; Liu C; Li Y; Deng Y
    Psychiatry Res; 2014 Jan; 221(1):92-6. PubMed ID: 24314908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.
    Brunswick DJ; Amsterdam JD; Mozley PD; Newberg A
    Am J Psychiatry; 2003 Oct; 160(10):1836-41. PubMed ID: 14514499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationship between cumulative mercury exposure index and specific uptake ratio in the striatum on Tc-99m TRODAT SPECT.
    Lin CY; Liou SH; Hsiech CM; Ku MC; Tsai SY
    Clin Nucl Med; 2011 Aug; 36(8):689-93. PubMed ID: 21716022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher striatal dopamine transporters in euthymic patients with bipolar disorder: a SPECT study with [Tc] TRODAT-1.
    Chang TT; Yeh TL; Chiu NT; Chen PS; Huang HY; Yang YK; Lee IH; Lu RB
    Bipolar Disord; 2010 Feb; 12(1):102-6. PubMed ID: 20148872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopamine transporter availability in drug-naive patients with schizophrenia: a case-control SPECT study with [(99m)Tc]-TRODAT-1 and a meta-analysis.
    Chen KC; Yang YK; Howes O; Lee IH; Landau S; Yeh TL; Chiu NT; Chen PS; Lu RB; David AS; Bramon E
    Schizophr Bull; 2013 Mar; 39(2):378-86. PubMed ID: 22156764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers--a SPECT study.
    Chen PS; Yang YK; Yeh TL; Lee IH; Yao WJ; Chiu NT; Lu RB
    Neuroimage; 2008 Mar; 40(1):275-9. PubMed ID: 18096411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
    Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
    Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early white matter injuries associated with dopamine transporter dysfunction in patients with acute CO intoxication: A diffusion kurtosis imaging and Tc-99m TRODAT-1 SPECT study.
    Chou MC; Lai PH; Li JY
    Eur Radiol; 2019 Mar; 29(3):1375-1383. PubMed ID: 30143836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies.
    Proebstl L; Kamp F; Manz K; Krause D; Adorjan K; Pogarell O; Koller G; Soyka M; Falkai P; Kambeitz J
    Eur Psychiatry; 2019 Jun; 59():15-24. PubMed ID: 30981746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
    Bor-Seng-Shu E; Pedroso JL; Felicio AC; de Andrade DC; Teixeira MJ; Braga-Neto P; Batista IR; Barsottini OG; Borges V; Ferraz HB; Shih MC; Bressan RA; de Andrade LA; Walter U
    Parkinsonism Relat Disord; 2014 May; 20(5):477-81. PubMed ID: 24629800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.